Federal Health Grants

This funding opportunity provides $6 million to the National Center for Missing & Exploited Children to enhance their operations in preventing child abduction and sexual exploitation, supporting families, and assisting law enforcement and community stakeholders.

This funding opportunity supports national nonprofit organizations in providing training and technical assistance to community coalitions focused on preventing substance use among adolescents.

This grant provides financial support for early-career cancer researchers transitioning to independent faculty positions, with a focus on promoting diversity and enhancing their professional development.

This funding opportunity provides financial support for researchers and organizations to investigate the underlying causes of neuropsychiatric symptoms in individuals with Alzheimer's disease, aiming to develop new treatments and interventions.

The Mississippi Delta is a historically and culturally rich region of the United States. The architecture, French, Spanish, British, and German, is as diverse as the people whose origins are European, Native American, Spanish, African, and more. But for all its cultural wealth, there is a poverty of health and healthcare in the region. Residents of the 18-county region contend with persistent poor health outcomes compounded by challenges to attaining preventive services and care, poor quality of care, and stagnant opportunity structures, particularly as it relates to cardiovascular disease (CVD).Roughly 1 in 10 (9.9% 28.6 million) adults in the US have at least 1 type of CVD, including coronary heart disease, heart failure, or stroke. This number excludes hypertension, a risk factor for and cause of CVD but not a type of CVD. However, hypertension or high blood pressure is a critical risk factor for stroke. An estimated 120 million American adults (48.1%) have it, most (3 in 4) dont have it controlled, and 1 in 5 adults is unaware they have hypertension.In 2012 CVD, particularly heart disease, was the leading cause of death in the Delta (244.4 deaths per 100,000). The regions residents experience age-adjusted death rates due to heart disease, stroke, and other CVDs that are considerably higher than national rates and the rest of Mississippi. According to the 2018 Cardiovascular Health Examination Survey (CHES) in the Mississippi Delta, the adjusted overall prevalence of hypertension among adults in the region 18 and older was 42.8%.The persistence of these outcomes in the Delta is attributable to modifiable CVD conditions and risk factors, such as high blood pressure, high cholesterol, coronary heart disease, COPD, chronic kidney disease, diabetes, and stroke. To sufficiently address these conditions, interventions must include evidence-based and practice-based approaches that are innovative and tailored to the unique challenges and strengths of the 18-county MS Delta Region. These interventions are needed in strategies that are focused on health systems, team-based care, and linkages to community resources and clinical services that address the social conditions that contribute to the prevalence of CVD in the MS Delta Region. This cooperative agreement builds from lessons learned from previous iterations. It focuses on policy, systems, and environmental changes that impact clinical and community settings and lifestyle changes that reduce uncontrolled blood pressure and CVD within the MS Delta Region.

This grant provides funding for collaborative projects between academic institutions and industry partners to develop innovative diagnostic and treatment technologies that address specific health challenges.

This funding opportunity is designed to establish a central hub for coordinating research on the genetics of Alzheimer’s disease, inviting diverse organizations to collaborate and manage genetic data to advance understanding and treatment of the condition.

The "Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce" grant aims to fund educational programs that inspire individuals from diverse and underrepresented backgrounds to pursue careers or further studies in biomedical and behavioral sciences through mentoring activities.

This funding opportunity provides financial support to nonprofit organizations and government agencies to create projects that incentivize SNAP households to purchase and consume healthy fluid milk.

This funding opportunity provides financial support to organizations working to improve access to HIV prevention, testing, and treatment services for vulnerable populations in South Sudan, with a focus on building local capacity and addressing health disparities.

The National Institute on Minority Health and Health Disparities (NIMHD), with other NIH Institutes and Centers (ICs) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications from National Cancer Institute (NCI)-designated Cancer Centers with existing community outreach and collaborations with American Indian and Alaska Native populations for research on improving cancer outcomes. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Summer 2024 with an expected application due date in Summer 2024. This NOFO will utilize the U01 activity code. Details of the planned NOFO are provided below.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this NOFO is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This NOFO is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required.

This grant provides funding for postdoctoral researchers from diverse backgrounds to receive training in translational research focused on Alzheimer's Disease and related dementias, enhancing their skills in interdisciplinary science and addressing health disparities.

This funding opportunity supports researchers and teams developing advanced imaging technologies to visualize the inner ear's structures and functions in living humans, aiming for greater detail and accuracy in non-invasive clinical settings.

This grant provides financial support for academic training to develop qualified rehabilitation professionals in high-demand areas, such as vocational rehabilitation counseling, to address personnel shortages in services for individuals with disabilities.

This funding initiative provides financial support to local Nigerian organizations focused on improving primary healthcare systems, particularly in maternal, newborn, child, and adolescent health, as well as malaria care.

This funding opportunity provides financial support to state and local governments, as well as tribal organizations, to equip first responders and community partners with the resources needed to combat the opioid overdose crisis through training, medication distribution, and support services for individuals affected by substance misuse.

The purpose of this program is to support communities to directly increase the diagnoses, treatment, and prevention of Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and syphilis. Successful applicants will work toward a reduction of new HIV infections and relevant co-morbidities, specifically syphilis and HCV infections; improve HIV/HCV/syphilis-related health outcomes; and reduce HIV/HCV/syphilis-related health disparities among American Indian and Alaska Native (AI/AN) people. In four separate but related parts, this initiative aims to implement effective and innovative strategies, interventions, approaches, and services to reduce new HIV/HCV/syphilis infections among AI/AN communities in the U.S. This initiatives overarching goals are to: (1) Reduce new HIV, HCV, and syphilis infections to less than 3,000 per year by 2030; and (2) achieve a 90 percent reduction in new HCV infections and a 65 percent reduction in mortality, compared to a 2015 baseline.

This funding opportunity provides financial support for recent KL2/K12 scholars from the NCATS CTSA Program to conduct small research projects that address challenges in translational science and help them transition to independent academic researchers.

NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31) aims to support and develop promising predoctoral candidates from underrepresented backgrounds in Alzheimer's disease research by providing financial support and mentorship to enhance their skills in data science and drug discovery.